Ilia A. Kuzmichev

Mr. Ilia A. Kuzmichev

Pirogov Russian National Research Medical University, Moscow, Moskva, Russia
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AIAnna Ivanova
Anna Ivanova
AKAlexsandra Kutuzova
Alexsandra Kutuzova
IKIlia A. Kuzmichev
Ilia A. Kuzmichev
Maxim AbakumovMaxim Abakumov
Maxim Abakumov
Alzheimer’s disease (AD) is the most common cause of dementia worldwide, and there are still no strategies to slow or prevent its clinical progression. Significant financial and research resources have been invested into studying the pathology of AD. However, its pathogenesis is not fully understood. This review provides a comprehensive analysis of current understanding of AD pathogenesis, including classical hypotheses (amyloid cascade, tau pathology, neuroinflammation, oxidative stress), emerging mechanisms (cellular senescence, endoplasmic reticulum stress, ubiquitin-proteasome system dysfunction), and alternative mechanisms (cholinergic dysfunction, glutamate excitotoxicity, disruption of the microbiota–gut–brain axis, and autophagy). Schematic illustrations summarize the relationships between the hypotheses and their role in the pathogenesis of AD. Particular attention is paid to the systematization of promising biological targets and the analysis of modern ligands of various nature, including small molecules, peptides, antibodies and their fragments, natural compounds, as well as innovative hybrid and multifunctional structures. A separate section is devoted to radiopharmaceuticals for PET imaging (Florbetaben, Flortaucipir, etc.) and promising therapeutic agents. Thus, in this review we (1) systematize modern concepts of AD pathogenesis, including classical, emerging mechanisms and alternative hypotheses; (2) conduct a comparative analysis of ligand classes (small molecules, peptides, antibodies, etc.) and their therapeutic potential; and (3) discuss the clinical prospects of radiopharmaceuticals for PET imaging and targeted therapy. The work provides a comprehensive analysis of modern approaches, which can help in the development of more effective drugs against AD.

1 October 2024 in Russian Chemical Reviews
Verified
Journal Article
Closed access
DSDaniil Spector
Daniil Spector
DADaniil S. Abramchuk
Daniil S. Abramchuk
VBV. V. Bykusov
V. V. Bykusov
AZA. O. Zharova
A. O. Zharova
EEE. S. Egorova
E. S. Egorova
OKOlga Krasnovskaya
Olga Krasnovskaya
BODIPY chromophores (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene) are one of the most versatile fluorophores which are commonly used in a variety of scientific fields. The combination of excellent photophysical properties with the possibility of easy chemical modification of structure, chemical and photostability determines the application of BODIPY in biomedicine, photocatalysis, analytical chemistry and materials science. This review summarizes approaches to the synthesis and modification of BODIPY, discussing both classical and recently-published synthetic and postfunctionalization approaches. An influence of BODIPY structure and various postfunctionalization methods on photophysical properties of the fluorophores and their potential applications in biomedicine, materials science and biosensorics are also discussed. The bibliography includes 344 references.

19 July 2024 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DADaniil Abramchuk
Daniil Abramchuk
AVAlevtina Voskresenskaya
Alevtina Voskresenskaya
IKIlia A. Kuzmichev
Ilia A. Kuzmichev
AEAlexander Erofeev
Alexander Erofeev
PGPeter Gorelkin
Peter Gorelkin
OKOlga Krasnovskaya
Olga Krasnovskaya

8 November 2024 in ACS Applied Nano Materials
Verified
Journal Article
Closed access
DSDaniil Spector
Daniil Spector
VBVladislav Bykusov
Vladislav Bykusov
AZAnastasia Zharova
Anastasia Zharova
IKIlia A. Kuzmichev
Ilia A. Kuzmichev
YIYulia A. Isaeva
Yulia A. Isaeva
OKOlga Krasnovskaya
Olga Krasnovskaya

17 October 2024 in ACS Omega
Verified
Journal Article
Open access
OKOlga Krasnovskaya
Olga Krasnovskaya
DADaniil Abramchuk
Daniil Abramchuk
AVAlexander Vaneev
Alexander Vaneev
PGPetr Gorelkin
Petr Gorelkin
Maxim AbakumovMaxim Abakumov
Maxim Abakumov
AEAlexander Erofeev
Alexander Erofeev
Five bifunctional copper chelating agents, Alz-(1-5), designed to prevent beta-amyloid (Aβ) aggregation, were synthesized, and the leader compound (Alz-5) was chosen. Alz-5 acts as a bifunctional chelator that can interact with various Aβ aggregates and reduce their neurotoxicity. Reactive oxygen species measurements provided by the Pt-nanoelectrode technique in single Aβ42-affected human neuroblastoma SH-SY5Y cells revealed significant antioxidant activity of Alz-5. AFM data obtained on Aβ42 fibrils clearly indicate the antiaggregating property of Alz-5. To gain insights into the changes in the physiomechanical properties of Aβ42-affected cells, as well as in order to evaluate the antiaggregating ability of Alz-5, Young's modulus mapping on living SH-SY5Y cells affected consequently by Aβ42 and Alz-5 was conducted, and the ability of Alz-5 to decrease cell rigidity induced by Aβ42 was indisputably proven. Low cell toxicity and antioxidating properties, in conjunction with AFM and SICM-based biophysical provided on Aβ42-affected SH-SY5Y cells, support Alz-5 as a potential inhibitor of Aβ aggregation.

24 September 2025 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
ANAleksey A. Nikitin
Aleksey A. Nikitin
LBLyubov Bondarenko
Lyubov Bondarenko
EIElizaveta Ivanova
Elizaveta Ivanova
VAVictor Arkhipov
Victor Arkhipov
IKIlia A. Kuzmichev
Ilia A. Kuzmichev
MAMaxim Abakumov
Maxim Abakumov